US EditionPublished • loading... • Updated
for the Tonix Pharmaceuticals Unveils Groundbreaking TNX-801 Mpox Vaccine Data at World Vaccine Congress Europe...
Summary by csimarket.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
for the Tonix Pharmaceuticals Unveils Groundbreaking TNX-801 Mpox Vaccine Data at World Vaccine Congress Europe...
Tonix Pharmaceuticals Showcases Promising Data for TNX-801 Mpox Vaccine at the World Vaccine Congress Europe 2025 In a significant stride towards combating mpox (formerly known as monkeypox) and smallpox, Tonix Pharmaceuticals announced their presentation of pivotal data on TNX-801, a live virus vaccine investigational candidate, during the World Vaccine Congress Europe 2025. The presentation garnered attention from industry experts, stakeholder…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
